eicosapentaenoic acid ethyl ester has been researched along with Muscle Disorders in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Congenital generalized lipodystrophy type 4 (CGL4) is a rare autosomal recessive condition with high rates of morbidity and mortality." | 1.72 | Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4. ( Babalola, F; Bulic, A; Curtis, J; Ng, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babalola, F | 1 |
| Ng, D | 1 |
| Bulic, A | 1 |
| Curtis, J | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Muscle Disorders
| Article | Year |
|---|---|
Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.
Topics: Adolescent; Eicosapentaenoic Acid; Female; Humans; Hypertriglyceridemia; Lipodystrophy; Lipodystroph | 2022 |